Triptorelin depot for the treatment of children 2 years and older with central precocious puberty
Authors:
- 3 July 2018
- journal article
- research article
- Published by Taylor & Francis in Expert Review of Clinical Pharmacology
- Vol. 11 (7) , 659-667
Abstract
Triptorelin depot is largely used to treat central precocious puberty (CPP) in children. Areas covered: This review updates triptorelin depot treatment of CPP, focusing on trials that compared 3.75 mg/28 day treated and untreated children till the adult height (AH). Efficacy of the new 11.25 mg/90 days or 22.5 mg/6 month formulations in suppressing pituitary-gonadal axis in short-term trials is also addressed. Short- and long-term safety was summarized. Expert commentary: Long experience on triptorelin depot use in children with CPP is available. Outcome differences on AH are reported; they may be due to heterogenicity of treated patients; some items remain to be optimized. No long term-adverse events on reproductive function are reported; additional studies would clarify if CPP per sè or triptorelin depot administration may increase hyperandrogenism and/or polycystic ovary syndrome risk in adulthood. The quarterly formulation seems to be able to suppress pituitary-gonadal axis and pubertal development and to determine similar end-results as monthly formulation, but additional trials are needed. Few data are available for the 22.5 mg/6 month formulation. Triptorelin depot treatment of CPP should be restricted to tertiary pediatric endocrinology centers, considering that some uncertainties still exist and that rare but serious adverse events may occur.Keywords
Funding Information
- not funded
This publication has 48 references indexed in Scilit:
- Central Precocious Puberty: Treatment with Triptorelin 11.25 mgThe Scientific World Journal, 2012
- Sterile abscess formation in response to two separate branded long-acting gonadotropin-releasing hormone agonistsClinical Therapeutics, 2010
- Growth Outcome during GnRH Agonist Treatments for Slowly Progressive Central Precocious PubertyNeuroendocrinology, 2009
- Adult height comparison between boys and girls with precocious puberty after long-term gonadotrophin-releasing hormone analogue therapyActa Paediatrica, 2007
- Presentation and evolution of organic central precocious puberty according to the type of CNS lesionClinical Endocrinology, 2006
- Long-term GnRH agonist treatment for female central precocious puberty does not impair reproductive functionMolecular and Cellular Endocrinology, 2006
- Treatment of central precocious pubertyBest Practice & Research Clinical Endocrinology & Metabolism, 2002
- Early puberty in girlsBest Practice & Research Clinical Endocrinology & Metabolism, 2002
- Precocious puberty: a follow up study.Archives of Disease in Childhood, 1984
- Tables for predicting adult height from skeletal age: Revised for use with the greulich-pyle hand standardsThe Journal of Pediatrics, 1952